<DOC>
	<DOCNO>NCT01081353</DOCNO>
	<brief_summary>To determine bioequivalence new formula aspirin relative establish commercial effervescent aspirin take orally healthy adult subject</brief_summary>
	<brief_title>Pharmacokinetic Study Comparing Aspirin Effervescent Aspirin</brief_title>
	<detailed_description />
	<mesh_term>Aspirin</mesh_term>
	<criteria>Healthy male female subject 18 55 year age inclusive Body Mass Index ( BMI ) approximately 18 30 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) Results screen clinical laboratory test within normal range consider clinically significant Principal Investigator Sponsor Female subject childbearing potential must use medically acceptable form birth control least 1 month prior screen ( 3 month oral contraceptive ) , e.g. , oral patch contraceptive , intrauterine device , DepoProvera , double barrier negative pregnancy test Screening Day 0 Dosing Period . Female subject nonchildbearing potential must amenorrheic least 2 year hysterectomy and/or bilateral oophorectomy Be willing participate schedule visit , treatment plan , laboratory test trial procedure accord clinical protocol History hypersensitivity aspirin ( ASA ) , Nonsteroidal Antiinflammatory Drugs ( NSAIDs ) , acetaminophen similar pharmacological agent component product Eighteen twenty year old viral infection , without fever , time dose Syndromes asthma , rhinitis nasal polyp Females pregnant lactate Have take ASA , ASAcontaining product , acetaminophen NSAID ( Over counter ( OTC ) prescription ) 7 day prior dose treatment period , trial treatment Smokers currently consume type tobacco product ( ) include smoke cessation nicotinecontaining product ( e.g. , nicotine patch , nicotine gum )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Aspirin</keyword>
	<keyword>Acetylsalicylic Acid</keyword>
</DOC>